Tissue and Stem Cell Therapeutics: Breakthroughs for Regenerative Medicine

20 Jan 2023
11:00
Modalities and Indications Track

11:00am Chair Introduction

John Rasko, Professor, University of Sydney

 

11:05am Presentation: TBA

Chris Min, Chief Executive Officer, Longeveron

 

11:20am Presentation: TBC

 Speaker TBC

 

11:35am Presentation: Tissue Therapeutics: Extending the Power of DNA and Cell-Based Approaches to Engineer Whole Tissues as Novel Therapeutics 

  • Built on 20+ years of research, this new class of regenerative medicine turns virtually any cell type into implantable bioengineered tissue
  • Tissue Therapeutics provides the adaptive and comprehensive cellular response needed to restore, repair or replace critical organ function impacted by progressive failures across multiple systems
  • Satellite Bio’s platform is positioned to address a broad range of complex diseases, replicating the high efficacy but reducing many of the complicating issues of the cell and gene approaches that have come before

Dave Lennon, Chief Executive Officer, Satellite Bio

 

11:50am Presentation: TBA

Jaeseung Lim, Chief Executive Officer and Chief Scientific Officer, Cellatoz Therapeutics

 

12:05pm Closing Panel with Q&A

With all session participants

Speakers

Chris Min
Chief Executive Officer & Chief Medical Officer
Longeveron
Dave Lennon
Chief Executive Officer
Satellite Bio
Jaeseung Lim
Chief Executive Officer & Chief Scientific Officer
Cellatz Therapeutics
John Rasko
Professor
University of Sydney